An investigation on behalf of investors in shares of Sarepta Therapeutics, Inc. (NASDAQ: SRPT) was announced over potential breaches of fiduciary duties by certain officers and directors at Sarepta Therapeutics, Inc. Investors who purchased shares of Sarepta Therapeutics, Inc. (NASDAQ: SRPT)Investigation announced for NASDSQ: SRPT Long-Term Investors over possible Wrongdoing at Sarepta Therapeutics, Inc. | openPR.com - New Public Relations: Business, Economy, Finances, Banking & Insurance
An investigation on behalf of investors in shares of Sarepta Therapeutics, Inc. (NASDAQ: SRPT) was announced over potential breaches of fiduciary duties by certain officers and directors at Sarepta Therapeutics, Inc. Investors who purchased shares of Sarepta Therapeutics, Inc. (NASDAQ: SRPT)